Cited by 117Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and OutcomesNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.

Translating the neuroscience of alcoholism into clinical treatments: From blocking the buzz to curing the blues

Open access

Heilig, Markus, Thorsell, Annika, Sommer, Wolfgang H., Hansson, Anita C., Ramchandani, Vijay A., George, David T., Hommer, Daniel, Barr, Christina S.·2010·Neuroscience & Biobehavioral Reviews

DOI 10.1016/j.neubiorev.2009.11.018PMC PMC2891917

Open this paper in CoChat — free account

Abstract

Understanding the pathophysiology of addictive disorders is critical for development of new treatments. A major focus of addiction research has for a long time been on systems that mediate acute positively reinforcing effects of addictive drugs, most prominently the mesolimbic dopaminergic (DA) system and its connections. This research line has been successful in shedding light on the physiology of both natural and drug reward, but has not led to therapeutic breakthroughs. The role of classical reward systems is perhaps least clear in alcohol addiction. Here, recent work is summarized that points to some clinically important conclusions. First, important pharmacogenetic differences exist with regard to positively reinforcing effects of alcohol and the ability of this drug to activate classical reward pathways. This offers an opportunity for personalized treatment approaches in alcoholism. Second, brain stress and fear systems become pathologically activated in later stages of alcoholism and their activation is a major influence in escalation of alcohol intake, sensitization of stress responses, and susceptibility to relapse. These findings offer a new category of treatment mechanisms. Corticotropin-releasing hormone (CRH) signaling through CRH1 receptors is a major candidate target in this category, but recent data indicate that antagonists for substance P (SP) neurokinin 1 (NK1) receptors may have a similar potential.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.neubiorev.2009.11.018

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The ‘Trier Social Stress Test’—a tool for investigating psychobiological stress responses in a laboratory setting
Kirschbaum, C., Pirke, K.-M., & Hellhammer, D. H. (2008) · Neuropsychobiology · doi:10.1159/000119004 · Cited by 6,093
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Characterization of a 41-Residue Ovine Hypothalamic Peptide that Stimulates Secretion of Corticotropin and β-Endorphin
Vale, W., Spiess, J., RIVIER, C. L., & Rivier, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,229
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Alcohol Abuse and Dependence in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908
International Affective Picture System (IAPS) : Technical Manual and Affective Ratings
Lang, P. J. (1995) · Medical Entomology and Zoology · Cited by 2,870
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622 · cited 1×
“…of addictive drugs may play an important role in early stages of addiction, but that addiction is a chronic relapsing disorder, ultimately maintained by pathology of brain function that arises over time, and only in a minority of subjects that initially engage in drug use (McLellan et al., 2000).”
Background
Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study
Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
An unidentified depressor substance in certain tissue extracts
von Euler, U. S., & Gaddum, J. H. (1931) · The Journal of Physiology · doi:10.1113/jphysiol.1931.sp002763 · Cited by 1,584
Addiction
Robinson, T. E., & Berridge, K. C. (2003) · Annual Review of Psychology · doi:10.1146/annurev.psych.54.101601.145237 · Cited by 1,509
Naltrexone and Coping Skills Therapy for Alcohol Dependence
O’Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,476
Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants.
Stewart, J., de Wit, H., & Eikelboom, R. (1984) · Psychological Review · doi:10.1037/0033-295x.91.2.251 · Cited by 1,261
Damage to the insula disrupts addiction to cigarette smoking
Naqvi, N. H., Rudrauf, D., Damasio, H., & Bechara, A. (2007) · Science · doi:10.1126/science.1135926 · Cited by 1,245
Transition from Moderate to Excessive Drug Intake: Change in Hedonic Set Point
Ahmed, S. H., & Koob, G. F. (1998) · Science · doi:10.1126/science.282.5387.298 · Cited by 1,186
Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction
Bond, C. E., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J. H., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,072
Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors
Kramer, M. S., Cutler, N. R., Feighner, J. P., Shrivastava, R. K., Carman, J. S., Sramek, J. J., Reines, S. A., Liu, G. F., Snavely, D. B., Wyatt-Knowles, E. S., et al. (1998) · Science · doi:10.1126/science.281.5383.1640 · Cited by 1,071
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,005
Understanding and preventing relapse.
Brownell, K. D., Marlatt, G. A., Lichtenstein, E., & Wilson, G. T. (1986) · American Psychologist · doi:10.1037/0003-066x.41.7.765 · Cited by 935
Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol.
Impérato, A., & Chiara, G. D. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23929-5 · Cited by 858
The hidden island of addiction: the insula
Naqvi, N. H., & Bechara, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.009 · Cited by 833 · cited 2×
“Interestingly, a key component of the network where sensitized activation is seen is the insula, a brain region that encodes negative interoceptive states, and whose anterior part has a high degree of reciprocal connectivity with the amygdala complex (Naqvi and Bechara, 2009).”
Background
Altered nociception, analgesia and aggression in mice lacking the receptor for substance P
Felipe, C. D., Herrero, J. F., O’Brien, J., Palmer, J. A., Doyle, C. A., Smith, A. J. H., Laird, J. M. A., Belmonte, C., Cerveró, F., & Hunt, S. P. (1998) · Nature · doi:10.1038/32904 · Cited by 755
Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants.
Weiss, F., Lorang, M. T., Bloom, F. E., & Koob, G. F. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39420-6 · Cited by 751
H1-Receptor Antagonists
Estelle, F., & Simons, R. (1994) · Drug Safety · doi:10.2165/00002018-199410050-00002 · Cited by 751
Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Spanagel, R. (2009) · Physiological Reviews · doi:10.1152/physrev.00013.2008 · Cited by 658
Drug addiction: the neurobiology of behaviour gone awry
Volkow, N. D., & Li, T. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1539 · Cited by 638
Drug addiction as dopamine-dependent associative learning disorder
Chiara, G. D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00372-6 · Cited by 607
Alcohol promotes dopamine release in the human nucleus accumbens
Boileau, I., Assaad, J., Pihl, R. O., Benkelfat, C., Leyton, M., Diksic, M., Tremblay, R. E., & Dagher, A. (2003) · Synapse · doi:10.1002/syn.10226 · Cited by 591
A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients
Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571
An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research
Amato, L., Davoli, M., A.Perucci, C., Ferri, M., Faggiano, F., & P. Mattick, R. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.007 · Cited by 567
Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565
Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction
Belin, D., Jonkman, S., Dickinson, A., Robbins, T. W., & Everitt, B. J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.027 · Cited by 520
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review
Alvarez, C. B., Magro, A., Ana, M., & María, A. J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00763.x · Cited by 504
An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence: Results From the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study
Anton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.2.135 · Cited by 451
Alcohol Dependence Produced in Mice by Inhalation of Ethanol: Grading the Withdrawal Reaction
Goldstein, D. B., & Pal, N. (1971) · Science · doi:10.1126/science.172.3980.288 · Cited by 432
Brain metabolic changes during cigarette craving
Brody, A. L., Mandelkern, M. A., London, E. D., Childress, A. R., Lee, G. S., Bota, R. G., Ho, M. L., Saxena, S., Baxter, L. R., Madsen, D., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.12.1162 · Cited by 425
Chemical Anatomy of the Brain
Hökfelt, T. G. M., Johansson, O., & Goldstein, M. (1984) · Science · doi:10.1126/science.6147896 · Cited by 415
Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat
Nakaya, Y., Kaneko, T., Shigemoto, R., Nakanishi, S., & Mizuno, N. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903470208 · Cited by 408
Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal
Rassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders
Holmes, A., Heilig, M. A., Rupniak, N. M. J., Steckler, T., & Griebel, G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.09.011 · Cited by 405
Self-citation
Alteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor
Valdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02448.x · Cited by 387
Alcohol dependence and anxiety disorders: what is the relationship?
Schuckit, M. A., & HESSELBROCK, V. M. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1723 · Cited by 383
Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms
Heilig, M. A., & Egli, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.001 · Cited by 382
Self-citation
Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats
Funk, C. K., O'Dell, L. E., Crawford, E. F., & Koob, G. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3096-06.2006 · Cited by 381
Additive Effect of Stress and Drug Cues on Reinstatement of Ethanol Seeking: Exacerbation by History of Dependence and Role of Concurrent Activation of Corticotropin-Releasing Factor and Opioid Mechanisms
Liu, X., & Weiss, F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07856.2002 · Cited by 362
CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat
Baldwin, H. A., Rassnick, S., Rivier, J., Koob, G. F., & Britton, K. T. (1991) · Psychopharmacology · doi:10.1007/bf02244208 · Cited by 353
Excessive Ethanol Drinking Following a History of Dependence Animal Model of Allostasis
Roberts, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00167-0 · Cited by 349
Enhanced Alcohol Self‐Administration after Intermittent Versus Continuous Alcohol Vapor Exposure
O’Dell, L. E., Roberts, A. J., Smith, R. T., & Koob, G. F. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000145781.11923.4e · Cited by 342
Long‐lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol
Rimondini, R., Arlinde, C., Sommer, W. H., & Heilig, M. A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0593com · Cited by 320
Self-citation
The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats
Lê, A. D., Harding, S. E., Juzytsch, W., Watchus, J., Shalev, U., & Shaham, Y. (2000) · Psychopharmacology · doi:10.1007/s002130000411 · Cited by 310
Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence
Sommer, W. H., Rimondini, R., Hansson, A. C., Hipskind, P. A., Gehlert, D. R., Barr, C. S., & Heilig, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.010 · Cited by 309
Self-citation
Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function
Santarelli, L., Gobbi, G., Debs, P. C., Sibille, E. L., Blier, P., Hen, R., & Heath, M. J. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1912 · Cited by 303
Neuropeptides and Inflammation: The Role of Substance P
Payan, D. G. (1989) · Annual Review of Medicine · doi:10.1146/annurev.me.40.020189.002013 · Cited by 284
Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats
Funk, C. K., Zorrilla, E. P., Lee, M.-J., Rice, K. C., & Koob, G. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.063 · Cited by 276
Why We Like to Drink: A Functional Magnetic Resonance Imaging Study of the Rewarding and Anxiolytic Effects of Alcohol
Gilman, J. M., Ramchandani, V. A., Davis, M. B., Bjork, J. M., & Hommer, D. W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0086-08.2008 · Cited by 267 · cited 2×
“(Gilman et al., 2008).”
MethodSelf-citation
Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress
Makino, S., Hashimoto, K., & Gold, P. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00791-8 · Cited by 260
Effects of Naltrexone on Alcohol Sensitivity and Genetic Moderators of Medication Response: A Double-blind Placebo-Controlled Study
Ray, L. A., & Hutchison, K. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1069 · Cited by 258
Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression
Kramer, M. S., Winokur, A., Kelsey, J. E., Preskorn, S., Rothschild, A. J., Snavely, D. B., Ghosh, K., Ball, W. A., Reines, S. A., Munjack, D. J., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300260 · Cited by 254
Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats
L�, A. D., Harding, S., Juzytsch, W., Funk, D. R., & Shaham, Y. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2036-y · Cited by 254
Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress
Hansson, A. C., Cippitelli, A., Sommer, W. H., Fedeli, A., Björk, K., Soverchia, L., Terasmaa, A., Massi, M. N., Heilig, M. A., & Ciccocioppo, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604419103 · Cited by 253
Self-citation
Effect of pattern and number of chronic ethanol exposures on subsequent voluntary ethanol intake in C57BL/6J mice
Lopez, M. F., & Becker, H. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0026-3 · Cited by 248
The Mu-Opioid Receptor Gene Polymorphism (A118G) Alters HPA Axis Activation Induced by Opioid Receptor Blockade
Wand, G. S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00294-9 · Cited by 247
Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats
Zorrilla, E. P., Valdez, G. R., & Weiss, F. (2001) · Psychopharmacology · doi:10.1007/s002130100773 · Cited by 246
3-(4-Chloro-2-Morpholin-4-yl-Thiazol-5-yl)-8-(1-Ethylpropyl)-2,6-Dimethyl-Imidazo[1,2-b]Pyridazine: A Novel Brain-Penetrant, Orally Available Corticotropin-Releasing Factor Receptor 1 Antagonist with Efficacy in Animal Models of Alcoholism
Gehlert, D. R., Cippitelli, A., Thorsell, A., Lê, A. D., Hipskind, P. A., Hamdouchi, C., Lu, J., Hembre, E. J., Cramer, J. W., Song, M., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4985-06.2007 · Cited by 239
Self-citation
Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake
Olive, M. F., Koenig, H. N., Nannini, M. A., & Hodge, C. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00748-1 · Cited by 237
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
Griebel, G., Simiand, J., Steinberg, R., Jung, M., Gully, D., Roger, P., Geslin, M., Scatton, B., Maffrand, J., & Soubrié, P. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.333 · Cited by 237
An overview of genetic influences in alcoholism.
Schuckit, M. A. (2009) · PubMed · Cited by 236
Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence
King, A. C., Volpicelli, J. R., Frazer, A., & O'Brien, C. P. (1997) · Psychopharmacology · doi:10.1007/s002130050156 · Cited by 227
Substance P in the medial amygdala: Emotional stress-sensitive release and modulation of anxiety-related behavior in rats
Ebner, K., Rupniak, N. M. J., Saria, A., & Singewald, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400794101 · Cited by 225
Increased Attributable Risk Related to a Functional μ-Opioid Receptor Gene Polymorphism in Association with Alcohol Dependence in Central Sweden
Bart, G. B., Kreek, M. J., Ott, J., LaForge, K. S., Proudnikov, D., Pollak, L., & Heilig, M. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300598 · Cited by 220
Self-citation
Substance P receptors: Localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand
Mantyh, P. W., Hunt, S. P., & Maggio, J. E. (1984) · Brain Research · doi:10.1016/0006-8993(84)90470-0 · Cited by 217
Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism
George, D. T., Gilman, J. M., Hersh, J., Thorsell, A., Herion, D. W., Geyer, C., Peng, X., Kielbasa, W., Rawlings, R. R., Brandt, J., et al. (2008) · Science · doi:10.1126/science.1153813 · Cited by 213
Self-citation
Brain mechanisms of drug reward and euphoria.
Wise, R. A., & Bozarth, M. A. (1985) · PubMed · Cited by 209
Rewarding effects of opiates are absent in mice lacking the receptor for substance P
Murtra, P., Sheasby, A. M., Hunt, S. P., & Felipe, C. D. (2000) · Nature · doi:10.1038/35012069 · Cited by 208
Cerebral Blood Flow Changes After Treatment of Social Phobia with the Neurokinin-1 Antagonist GR205171, Citalopram, or Placebo
Furmark, T., Appel, L., Michelgård, Å., Wahlstedt, K., Åhs, F., Zancan, S., Jacobsson, E., Flyckt, K., Grohp, M., Bergström, M., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.029 · Cited by 208
The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat
Rassnick, S., Stinus, L., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)90004-7 · Cited by 205
Opioid Receptor Gene (OPRM1, OPRK1, and OPRD1) Variants and Response to Naltrexone Treatment for Alcohol Dependence: Results From the VA Cooperative Study
Gelernter, J. E., Gueorguieva, R. V., Kranzler, H. R., Zhang, H., Cramer, J. A., Rosenheck, R. A., Krystal, J. H., & the VA Cooperative Study #425 Study Group (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00339.x · Cited by 204
A dopamine‐μ1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non‐psychostimulant drugs of abuse
Tanda, G., & Chiara, G. D. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00135.x · Cited by 200
Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
Valdez, G. R., Roberts, A., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · PubMed · doi:10.1097/01.alc.0000033120.51856.f0 · Cited by 187
High-priority communication I Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence
Valdez, G. R., Zorrilla, E. P., Roberts, A. J., & Koob, G. F. (2003) · Alcohol · doi:10.1016/s0741-8329(03)00020-x · Cited by 186
Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples
Treutlein, J., Kissling, C., Frank, J., Wiemann, S., Dong, L., Depner, M., Saam, C., Lascorz, J., Soyka, M., Preuss, U. W., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001813 · Cited by 186
Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden
Bart, G. B., Heilig, M. A., LaForge, K. S., Pollak, L., Leal, S. M., Ott, J., & Kreek, M. J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001504 · Cited by 179
Self-citation
Association of an Asn40Asp (A118G) polymorphism in the μ-opioid receptor gene with substance dependence: A meta-analysis
Arias, A. J., Feinn, R., & Kranzler, H. R. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.11.024 · Cited by 178
Expansion of the human μ-opioid receptor gene architecture: novel functional variants
Shabalina, S. A., Zaykin, D. V., Gris, P., Ogurtsov, A. Y., Gauthier, J., Shibata, K., Tchivileva, I. E., Belfer, I., Mishra, B. K., Kiselycznyk, C., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn439 · Cited by 174
REVIEW: Genetically selected Marchigian Sardinian alcohol‐preferring (msP) rats: an animal model to study the neurobiology of alcoholism
Ciccocioppo, R., Economidou, D., Cippitelli, A., Cucculelli, M., Ubaldi, M., Soverchia, L., Lourdusamy, A., & Massi, M. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00032.x · Cited by 170
Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors
Overstreet, D. H. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.010 · Cited by 169
Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalisation in guinea-pigs and mice
Rupniak, N. M. J., Carlson, E. C., Harrison, T., Oates, B. D., Seward, E. M., Owen, S. N., Felipe, C. D., Hunt, S. P., & Wheeldon, A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00052-6 · Cited by 168
Conceptual framework for the etiology of alcoholism: a “kindling”/stress hypothesis
Breese, G. R., Overstreet, D. H., & Knapp, D. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2016-2 · Cited by 167
Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice
Teixeira, R. M., Santos, A. R. S., Ribeiro, S. J., Calixto, J. Β., Rae, G. A., & de Lima, T. C. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00390-1 · Cited by 166
Accentuated Decrease in Social Interaction in Rats Subjected to Repeated Ethanol Withdrawals
Overstreet, D. H., Knapp, D. J., & Breese, G. R. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02665.x · Cited by 161
Antagonism by alpha methyltyrosine of the ethanol‐induced stimulation and euphoria in man
Ahlénius, S., Carlsson, A., Engel, J. A., Svensson, T. H., & dersten, P. S. (1973) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1973144part1586 · Cited by 155
Association between two µ-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence
Zhang, H., Luο, X., Kranzler, H. R., Lappalainen, J., Yang, B., Krupitsky, E. M., Zvartau, E. E., & Gelernter, J. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl024 · Cited by 153
Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK 1 ) receptor in assays for antidepressant and anxiolytic drugs
Rupniak, N. M. J., Carlson, E. J., Webb, J. K., Harrison, T., Porsolt, R. D., Roux, S., Felipe, C. D., Hunt, S. P., Oates, B. D., & Wheeldon, A. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200111000-00011 · Cited by 150
A Comparative Study on Alcohol‐Preferring Rat Lines: Effects of Deprivation and Stress Phases on Voluntary Alcohol Intake
Vengeliene, V., Siegmund, S., Singer, M. V., Sinclair, J. D., Li, T., & Spanagel, R. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000075829.81211.0c · Cited by 142
Brain Reward Systems and Abuse
Engel, J. A., & läkaresällskapet, S. (1987) · Medical Entomology and Zoology · Cited by 142
Alcohol cue reactivity: effects of detoxification and extended exposure.
Monti, P. M., Rohsenow, D. J., Rubonis, A. V., NIAURA, R. S., Sirota, A. D., Colby, S. M., & Abrams, D. B. (1993) · Journal of Studies on Alcohol · doi:10.15288/jsa.1993.54.235 · Cited by 141
Repeated cycles of chronic intermittent ethanol exposure in mice increases voluntary ethanol drinking and ethanol concentrations in the nucleus accumbens
Griffin, W. C., Lopez, M. F., Yanke, A. B., Middaugh, L. D., & Becker, H. C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1324-3 · Cited by 139
Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: Relationship to the reinstatement of alcohol seeking
Funk, D. R., Li, Z., & Lê, A. D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.062 · Cited by 138
Effect of Acute Ethanol Administration on the Release of Opioid Peptides From the Midbrain Including the Ventral Tegmental Area
Jarjour, S., Bai, L., & Gianoulakis, C. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00924.x · Cited by 132
Increased Anxiety‐Like Behavior and Ethanol Self‐Administration in Dependent Rats: Reversal via Corticotropin‐Releasing Factor‐2 Receptor Activation
Valdez, G. R., Sabino, V., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000128222.29875.40 · Cited by 131
SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats
Knapp, D. J., Overstreet, D. H., Moy, S. S., & Breese, G. R. (2004) · Alcohol · doi:10.1016/j.alcohol.2003.08.007 · Cited by 130
The Role of Corticotropin-Releasing Factor in the Median Raphe Nucleus in Relapse to Alcohol
Lê, A. D., Harding, S., Juzytsch, W., Fletcher, P. J., & Shaham, Y. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07844.2002 · Cited by 130
Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist
Breese, G. R., Overstreet, D. H., Knapp, D. J., & Navarro, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300706 · Cited by 124
Understanding US addiction physicians' low rate of naltrexone prescription
Mark, T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00134-0 · Cited by 120
The Gerbil Elevated Plus-maze II Anxiolytic-like Effects of Selective Neurokinin NK1 Receptor Antagonists
Varty, G. B. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00313-5 · Cited by 120
Family History of Alcoholism and Hypothalamic Opioidergic Activity
Wand, G. S., Mangold, D. L., El-Deiry, S., McCaul, M. E., & Hoover, D. R. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1114 · Cited by 118
Ethanol as a neurochemical surrogate of conventional reinforcers: The dopamine-opioid link
Chiara, G. D., Acquas, E., & Tanda, G. (1996) · Alcohol · doi:10.1016/0741-8329(95)02034-9 · Cited by 117
Anxiolytic Action of a Neurokinin1 Receptor Antagonist in the Social Interaction Test
File, S. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)90002-2 · Cited by 108
IMAGING STUDY: Modulation of brain response to emotional images by alcohol cues in alcohol‐dependent patients
Gilman, J. M., & Hommer, D. W. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00111.x · Cited by 107
Self-citation
Neurokinin-1 Receptor-Expressing Neurons in the Amygdala Modulate Morphine Reward and Anxiety Behaviors in the Mouse
Gadd, C. A., Murtra, P., Felipe, C. D., & Hunt, S. P. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-23-08271.2003 · Cited by 107
A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression
Miller, G. M., Bendor, J., Tiefenbacher, S., Yang, H. S., Novak, M. A., & Madras, B. K. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001378 · Cited by 106
Substance P in Stress and Anxiety
Ebner, K., Muigg, P., Singewald, G. M., & Singewald, N. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.018 · Cited by 106
Family History of Alcoholism Influences Naltrexone-Induced Reduction in Alcohol Drinking
Krishnan‐Sarin, S., Krystal, J. H., Shi, J. M., Pittman, B. P., & O’Malley, S. S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.018 · Cited by 105
Association of a Functional Polymorphism in the μ-Opioid Receptor Gene With Alcohol Response and Consumption in Male Rhesus Macaques
Barr, C. S., Schwandt, M., Lindell, S. G., Chen, S. A., Goldman, D., Suomi, S. J., Higley, J. D., & Heilig, M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.369 · Cited by 105 · cited 1×
“Using this model, we found increased psychomotor stimulation in response to alcohol, increased alcohol preference, and increased frequency of alcohol consumption at a level leading to intoxication in carriers of the rhesus (rh) OPRM1 77G variant (Barr et al., 2007).”
MethodSelf-citation
Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors
Ripley, T. L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00295-2 · Cited by 104
CLINICAL PREDICTORS OF RESPONSE TO NALTREXONE IN ALCOHOLIC PATIENTS: WHO BENEFITS MOST FROM TREATMENT WITH NALTREXONE?
Rubio, G., Ponce, G., Rodríguez–Jiménez, R., Jiménez‐Arriero, M. Á., Hoenicka, J., & Palomo, T. (2005) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh151 · Cited by 91
A temporal threshold for induction of persistent alcohol preference: behavioral evidence in a rat model of intermittent intoxication.
Rimondini, R., Sommer, W. H., & Heilig, M. A. (2003) · Journal of Studies on Alcohol · doi:10.15288/jsa.2003.64.445 · Cited by 91
Self-citation
PRECLINICAL STUDY: Region‐specific down‐regulation of Crhr1 gene expression in alcohol‐preferring msP rats following ad lib access to alcohol
Hansson, A. C., Cippitelli, A., Sommer, W. H., Ciccocioppo, R., & Heilig, M. A. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00050.x · Cited by 91
Self-citation
OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype‐Based Approach
Oroszi, G., Anton, R. F., O’Malley, S. S., Swift, R. M., Pettinati, H. M., Couper, D. J., Yuan, Q., & Goldman, D. A. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00846.x · Cited by 87
Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?
Egli, M. (2005) · Addiction Biology · doi:10.1080/13556210500314550 · Cited by 86
Heterogeneous Effects of Alcohol on Dopamine Release in the Striatum: A PET Study
Yoder, K. K., Constantinescu, C. C., Kareken, D. A., Normandin, M. D., Cheng, T., O’Connor, S., & Morris, E. D. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00390.x · Cited by 85
Getting closer to affective disorders: the role of CRH receptor systems
Müller, M. B., & Wurst, W. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.06.007 · Cited by 84
The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats
Papp, M., Vassout, A., & Gentsch, C. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00230-8 · Cited by 82
Repeated Cycles of Chronic Intermittent Ethanol Exposure Leads to the Development of Tolerance to Aversive Effects of Ethanol in C 57 BL /6 J Mice
Lopez, M. F., Griffin, W. C., Meléndez, R. I., & Becker, H. C. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01717.x · Cited by 82
Functional CRH variation increases stress-induced alcohol consumption in primates
Barr, C. S., Dvoskin, R. L., Gupte, M., Sommer, W. H., Sun, H., Schwandt, M. L., Lindell, S. G., Kasckow, J., Suomi, S. J., Goldman, D. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902863106 · Cited by 81
Self-citation
Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat
Amalric, M., & Koob, G. F. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90014-0 · Cited by 79
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
Gully, D., Geslin, M., Serva, L., Fontaine, E., Roger, P., Lair, C., Darre, V., MARCY, C. H., Rouby, P.-E., Simiand, J., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.322 · Cited by 78
On the role of ascending dopamine systems in the control of voluntary ethanol intake and ethanol intoxication
Kiianmaa, K., Andersson, K., & Fuxé, K. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90240-5 · Cited by 72
Development of an Alcohol Deprivation and Escalation Effect in C57BL/6J Mice
Meléndez, R. I., Middaugh, L. D., & Kalivas, P. W. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00248.x · Cited by 71
Suppression of Alcohol Preference by Naltrexone in the Rhesus Macaque: A Critical Role of Genetic Variation at the μ-Opioid Receptor Gene Locus
Barr, C. S., Chen, S. A., Schwandt, M. L., Lindell, S. G., Sun, H., Suomi, S. J., & Heilig, M. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.026 · Cited by 58
Self-citation
Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist
Ballard, T. M., Sänger, S., & Higgins, G. A. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00724-5 · Cited by 58
Neurokinin 1 Receptor Antagonism Promotes Active Stress Coping Via Enhanced Septal 5-HT Transmission
Ebner, K., Singewald, G. M., Whittle, N., Ferraguti, F., & Singewald, N. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301594 · Cited by 50
Increased anxiety and other similarities in temperament of alcoholics with and without antisocial personality disorder across three diverse populations
Ducci, F., Enoch, M., Funt, S. A., Virkkunen, M. E., Albaugh, B., & Goldman, D. A. (2007) · Alcohol · doi:10.1016/j.alcohol.2007.02.005 · Cited by 49
Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release
Ebner, K., & Singewald, N. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0185-3 · Cited by 49
Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: implication of substance P in aversion
Elliott, P. J. (1988) · Experimental Brain Research · doi:10.1007/bf00248227 · Cited by 47
Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence
Kakko, J., von Wachenfeldt, J., Svanborg, K. D., Lidström, J., Barr, C. S., & Heilig, M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.001 · Cited by 41
Self-citation
Pharmacogenetic studies of alcohol self-administration and withdrawal
Crabbe, J. C., & Phillips, T. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1608-6 · Cited by 40
Untitled work
(1971) · doi:10.1002/1097-4679(197110)27:4

Research works printed but not linked: 1

Thorsell A Schank JR Singley E Hunt SP Heilig M 2009 The neurokinin-1 receptor is required for alcohol reward and escalation of alcohol intake In press PNAS

Sorted by citations

Opiate versus psychostimulant addiction: the differences do matter
Badiani, A., Belin, D., Epstein, D. H., Calu, D. J., & Shaham, Y. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3104 · Cited by 491
Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders
Kwako, L. E., Momenan, R., Litten, R. Z., Koob, G. F., & Goldman, D. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.10.024 · Cited by 395
Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients
Sjoerds, Z., de Wit, S., van den Brink, W., Robbins, T. W., Beekman, A. T. F., Penninx, B. W. J. H., & Veltman, D. J. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.107 · Cited by 312
Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse
Breese, G. R., Sinha, R., & Heilig, M. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.007 · Cited by 274
Self-citation
Corticotropin releasing factor: A key role in the neurobiology of addiction
Zorrilla, E. P., Logrip, M. L., & Koob, G. F. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.01.001 · Cited by 267

See all 117

Authors: Heilig, M., Thorsell, A., Sommer, W. H., Hansson, A. C., Ramchandani, V. A., George, D. T., Hommer, D., & Barr, C. S.
Affiliations: National Institutes of Health (US)
Corresponding author: Heilig, Markus
ORCID: Heilig, Markus
Thorsell, Annika
Sommer, Wolfgang H.
Hansson, Anita C.
Ramchandani, Vijay A.
George, David T.
Barr, Christina S.
Venue: Neuroscience & Biobehavioral Reviews
Publisher: Elsevier BV
Published: 2010-11
Volume: 35
Issue: 2
Pages: 334-344
ISSN: 0149-7634 (ISSN-L)
DOI: 10.1016/j.neubiorev.2009.11.018
PMC: PMC2891917
OpenAlex: W2010733076
Cited by: 117
References: 144
Citations by year: 2026: 2 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 5 · 2018: 3 · 2017: 11 · 2016: 9 · 2015: 11 · 2014: 13 · 2013: 9 · 2012: 15
FWCI: 4.99
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuroscience & Biobehavioral Reviews (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism (ZIAAA000487)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: alcoholism, mesolimbic dopamine system, drug reward, pharmacogenetics, personalized treatment, relapse, corticotropin-releasing factor, substance P, NK1 receptor antagonists
MeSH terms: CRF Receptor, Type 1, Ethanol, Alcoholism, Animals, Brain, Corticotropin-Releasing Hormone, Humans, Models, Biological, Substance P, Drug Delivery Systems, Receptors, Corticotropin-Releasing Hormone, Translational Research, Biomedical, Neurokinin-1 Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Translating the neuroscience of alcoholism into clinical treatments: From blocking the buzz to curing the blues

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks